Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma.
Jethava Y, Mitchell A, Zangari M, Waheed S, Schinke C, Thanendrarajan S, Sawyer J, Alapat D, Tian E, Stein C, Khan R, Heuck CJ, Petty N, Avery D, Steward D, Smith R, Bailey C, Epstein J, Yaccoby S, Hoering A, Crowley J, Morgan G, Barlogie B, van Rhee F.
Jethava Y, et al. Among authors: barlogie b.
Blood Cancer J. 2016 Jul 29;6(7):e453. doi: 10.1038/bcj.2016.64.
Blood Cancer J. 2016.
PMID: 27471869
Free PMC article.
Clinical Trial.